Amid the din of debates about screening mammography overuse, some women still remain underserved.

Although I’m an avowed word person, I have to admit sometimes numbers, rather than words, best convey the story. This week definitely falls into that category.

Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and aviation security technology, announced today that it will showcase its full suite of ultrasound imaging solutions, which offer clinicians a potentially faster and easier way to maximize ultrasound performance in urology and renal imaging, at the American Urological Association (AUA) Annual Meeting, May 4-8, in San Diego.

Viztek, a leading provider of complete digital software and hardware diagnostic imaging solutions, introduces the Leggera Wireless Panel, expanding the Leggera DR (Direct Radiography) Solutions product line to now include the lightest - 6.1 lb, ISO 4090 cassette size- wireless panel available to the market.

Carestream has been awarded a three-year agreement by Novation, a leading healthcare supply chain expertise and contracting company, to offer CARESTREAM Vue RIS+PACS, CARESTREAM Cardiology PACS and CARESTREAM Vue for Vendor-Neutral Archive to the members Novation serves.

Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products with an emphasis on serving the healthcare needs of women, today announced the publication of the final results of a large-scale prospective study comparing breast cancer screening using Hologic’s 2D mammography plus tomosynthesis (Breast Tomosynthesis) with conventional 2D mammography published online in advance of print by The Lancet Oncology.

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) heads north June 8 to June 12 to Vancouver for its annual meeting, dubbed as the premiere educational and networking event in molecular imaging and nuclear medicine.

Poor patient outcomes are associated with primary breast cancer that has metastasized to internal mammary lymph nodes. Researchers compared F-18 FDG PET/CT with results of cytopathologic testing from image-guided fine-needle aspiration, revealing a high percentage of proven metastases from positive FDG PET scans, according to a study published in the May issue of the American Journal of Roentgenology.